Pulse Biosciences, Inc.
PLSENASDAQHealthcare● Active
$25.36
+$0.03(+0.12%)
Market Cap$1.8B
P/E Ratio—
52W High$27.98
52W Low$12.56
Pulse Biosciences, Inc. (PLSE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PLSE · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.35M | $0.00M | $0.00M | $0.70M | $1.42M |
| Cost of Revenue | $1.61M | $0.00M | $1.21M | $11.94M | $1.97M |
| Gross Profit | ($1.26M) | $0.00M | ($1.21M) | ($11.24M) | ($0.55M) |
| Gross Margin %(computed) | -360.00% | — | — | — | -38.79% |
| Operating Expenses | |||||
| R&D Expenses | $44.72M | $32.34M | $27.80M | $20.84M | $28.64M |
| G&A Expenses | $0.00M | $23.92M | $15.78M | $13.96M | $19.07M |
| Total Operating Expenses | $75.68M | $56.26M | $42.37M | $46.81M | $62.46M |
| Operating Income | ($76.94M) | ($56.26M) | ($43.57M) | ($58.06M) | ($63.01M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $4.21M | $2.67M | $2.46M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $1.10M | $0.00M | $0.00M |
| Income Before Tax | ($72.78M) | ($53.59M) | ($42.21M) | ($58.51M) | ($63.66M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($72.78M) | ($53.59M) | ($42.21M) | ($58.51M) | ($63.66M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.08 | $-0.92 | $-0.88 | $-1.72 | $-2.28 |
| Wtd Avg Shares | 67.40M | 58.40M | 48.04M | 33.94M | 27.96M |
| EBITDA | ($71.71M) | ($55.08M) | ($42.37M) | ($56.70M) | ($61.87M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Pulse Biosciences, Inc. data
About Pulse Biosciences, Inc. (PLSE) Income Statement
Pulse Biosciences, Inc. (PLSE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PLSE reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -360.00%), and net income of ($0.07B) — a net profit margin of -20794.57%.
Frequently asked questions
PLSE · 4 questionsPulse Biosciences, Inc. (PLSE) reported revenue of $0.00B for 2025, up —% year-over-year.
PLSE revenuePLSE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08